13-azaprostanoic acid has been researched along with calcimycin in 1 studies
| Studies (13-azaprostanoic acid) | Trials (13-azaprostanoic acid) | Recent Studies (post-2010) (13-azaprostanoic acid) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 42 | 0 | 0 | 11,946 | 40 | 444 |
| Protein | Taxonomy | 13-azaprostanoic acid (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaibuchi, K; Kikuchi, A; Takai, Y; Tanimoto, T; Tsuda, T | 1 |
1 other study(ies) available for 13-azaprostanoic acid and calcimycin
| Article | Year |
|---|---|
Enhancement of collagen-induced phosphoinositide turnover by thromboxane A2 analogue through Ca2+ mobilization in human platelets.
Topics: Blood Platelets; Calcimycin; Calcium; Collagen; Cytoplasm; Humans; Indomethacin; Myosins; Phosphatidic Acids; Phosphatidylinositols; Phosphorylation; Prostanoic Acids; Thromboxane A2 | 1985 |